prednisone has been researched along with Infusion Site Adverse Event in 1 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, KM | 1 |
| Keam, B | 1 |
| Ha, H | 1 |
| Kim, M | 1 |
| Jung, JW | 1 |
| Song, WJ | 1 |
| Kim, TM | 1 |
| Jeon, YK | 1 |
| Kang, HR | 1 |
| Kim, DW | 1 |
| Kim, CW | 1 |
| Heo, DS | 1 |
1 other study available for prednisone and Infusion Site Adverse Event
| Article | Year |
|---|---|
Clinical significance of rituximab infusion-related reaction in diffuse large B-cell lymphoma patients receiving R-CHOP.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclopho | 2019 |